These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6176411)

  • 1. Serum activities of lysosomal enzymes in patients with liver cell carcinoma.
    Nagasue N; Inokuchi K; Kanashima R
    Dig Dis Sci; 1982 May; 27(5):454-8. PubMed ID: 6176411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of lysosomal enzymes after partial hepatectomy: study of patients with and without cirrhosis of the liver.
    Nagasue N; Inokuchi K; Kanashima R
    Arch Surg; 1982 Jun; 117(6):772-6. PubMed ID: 6282236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinoma.
    Shimokawa Y; Okuda K; Kubo Y; Kaneko A; Arishima T; Nagata E; Hashimoto M; Sawa Y; Nagasaki Y; Kojiro M; Sakamoto K; Nakashima T
    Cancer; 1977 Jul; 40(1):319-24. PubMed ID: 195707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of serum immunoreactive beta-glucuronidase: a possible serological marker for histological hepatic cell necrosis and to predict the histological progression of hepatitis].
    Ohta H
    Hokkaido Igaku Zasshi; 1991 Jul; 66(4):545-57. PubMed ID: 1655603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of type III procollagen peptide in sera of patients with liver cancer].
    Yamauchi M; Nakayama H; Fukuzawa K; Nakajima H; Takahara M; Nakahara M; Kawase H; Watanabe Y; Kimura K; Kitahara T
    Gan No Rinsho; 1984 Jun; 30(7):785-90. PubMed ID: 6086978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enzyme diagnosis in primary liver carcinoma].
    Schmidt E; Schmidt FW
    Dtsch Med Wochenschr; 1968 Jun; 93(23):1153-5. PubMed ID: 5648362
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of the release of hepatic enzymes in various liver diseases. 1. Alterations in cytoplasmic and mitochondrial enzyme activities in serum.
    Miyake S
    Acta Med Okayama; 1979 Aug; 33(4):287-304. PubMed ID: 227231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between serum enzymes and serum unsaturated vitamin B12 binding proteins in primary liver carcinoma.
    Osifo BO; Ayoola A; Parmentier Y; Gerard P; Nicolas JP
    Enzyme; 1988; 39(3):161-6. PubMed ID: 2837386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of endotoxin administration on hepatic function of rats with altered endotoxin sensitivity.
    Di Luzio NR; Trejo RA; Crafton CC
    J Reticuloendothel Soc; 1972 Jun; 11(6):637-53. PubMed ID: 5046176
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between hepatitis-associated antigen and the development of hepatocellular cancer.
    Theodoropoulos G; Economopoulos P; Mitakos S; Angelopoulos Ba
    Acta Hepatogastroenterol (Stuttg); 1974 Dec; 21(6):430-2. PubMed ID: 4377058
    [No Abstract]   [Full Text] [Related]  

  • 12. N-acetylglucosaminyltransferase III in human serum, and liver and hepatoma tissues: increased activity in liver cirrhosis and hepatoma patients.
    Ishibashi K; Nishikawa A; Hayashi N; Kasahara A; Sato N; Fujii S; Kamada T; Taniguchi N
    Clin Chim Acta; 1989 Dec; 185(3):325-32. PubMed ID: 2482796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal enzymes in sera and granulocytes of patients with chronic liver diseases.
    Fehér J; Toncsev H; Fehér E; Kiss A; Vasady A
    Int J Tissue React; 1981 Mar; 3(1):31-7. PubMed ID: 7287055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
    Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
    Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Primary liver cancer. A review of the clinical features, blood groups, serum enzymes, therapy, and survival of 65 cases.
    al-Sarraf M; Go TS; Kithier K; Vaitkevicius VK
    Cancer; 1974 Feb; 33(2):574-82. PubMed ID: 4360057
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enzymatic parameters in diagnosis of fatty liver ].
    Nilius R; Peters JE; Farr W; Gründig CA; Otto L; Busse HJ; Zipprich B; Eismann R; Mantel E
    Z Gesamte Inn Med; 1973 Sep; 28(17):268-70 passim. PubMed ID: 4148891
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective secretion of lysosomal enzymes of the Yoshida hepatoma AH 130 in the peritoneal fluid.
    Hegner D; Platt D
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972 Dec; 78(4):310-6. PubMed ID: 4354866
    [No Abstract]   [Full Text] [Related]  

  • 18. Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications.
    Leto G; Tumminello FM; Pizzolanti G; Montalto G; Soresi M; Gebbia N
    Oncology; 1997; 54(1):79-83. PubMed ID: 8978598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lysosomal enzymes after liver transplantation in the pig.
    Chang CW; Imai K; Chang YC; Hayashi T; Kohno H; Nagasue N; Nakamura T
    Enzyme; 1991; 45(3):145-54. PubMed ID: 1815948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers.
    Kuo WH; Chou FP; Lu SC; Chu SC; Hsieh YS
    Clin Chim Acta; 2000 Apr; 294(1-2):157-68. PubMed ID: 10727681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.